A standardized sentinel lymph node enhanced pathology protocol (SEPP) in patients with breast cancer

Journal of Surgical Oncology

Volumn 96, Issue 6, 2007, Pages 470-473

  Fortunato, L ^a   Amini, M ^a   Costarelli, L ^a   Piro, F R ^a   Farina, M ^a   Vitelli, C E ^a  

^a SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

Author keywords

Breast cancer; Enhanced pathology; Immunohistochemistry; Sentinel lymph node

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL PROTOCOL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY;

BREAST NEOPLASMS; HEMATOXYLIN; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MODELS, BIOLOGICAL; SENTINEL LYMPH NODE BIOPSY;

EID: 35748938476     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20767     Document Type: Article

References (14)

1. Cserni GC, Amendoira I, Apostolikas N, et al.: Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Path 2004;57:695-701.
2. Veronesi U, Zurrida S, Mazzarol G, et al.: Extensive frozen section examination of axillary sentinel nodes to determine selective axillary dissection. World J Surg 2001;25:806-808.
3. Silverberg SG: Sentinel node processing. Recommendations for pathologists. Am J Surg Pathol 2002;26:383-385.
4. Fortunato L, Amini M, Farina M, et al.: Intraoperative examination of sentinel nodes in breast cancer: Is the glass half full or half empty? Ann Surg Oncol 2004;11:1005-1010.
5. Dowlatshahi K, Fan M, Snider HC, Habib FA: Lymph node micrometastases from breast carcinoma: Reviewing the dilemma. Cancer 1997;80:1188-1189.
6. International (Ludwig) Breast Cancer Study Group: Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990;335:1565-1568.
7. Colleoni M, Rotmensz N, Peruzzotti G, et al.: Size of breast cancer metasatases in axillary lymph nodes: Clinical relevance of minimal lymph node involvement. J Clin Oncol 2005;23:1379-1389.
8. Susnik B, Frkovic-Grazio S, Bracko M: Occult micrometastases in axillary lymph nodes predict subsequent distant metastases in Stage I breast cancer: A case control study with 15-year follow up. Ann Surg Oncol 2004;11:568-572.
9. Cserni G: Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol 2002;55:926-931.
10. Torrenga H, Rahusen FD, Meijer S, et al.: Sentinel node investigation in breast cancer: Detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 2001;54:550-552.
11. Freneaux P, Nos C, Vincent-Salomon A, et al.: Histological detection of minimal metastatic involvement in axillary sentinel nodes: A rational basis for a sensitive methodology usable in daily practice. Mod Pathol 2002;15:641-646.
12. Motomura K, Komoike Y, Inaji H, et al.: Multiple sectioning and immunohistochemical staining of sentinel nodes in patients with breast cancer. Br J Surg 2002;89:1032-1034.
13. Liu LH, Siziopikou KP, Gabram S, et al.: Evaluation of axillary sentinel lyph node biopsy by immunohistochemistry and multilevel sectioning in patients with breast carcinoma. Arch Pathol Lab Med 2000;124:1670-1673.
14. Moore KH, Thaler HT, Tan LK, et al.: Immunohistochemically detected tumor cells in the sentinel lymph nodes of patients with breast carcinoma: Biologic metastasis or procedural artifact? Cancer 2004;100:929-934.